AltruBio lands up to $225M after shift to immune drug research
BioPharma
Source: biopharmadive.com
📰 Jake Simson News
Jake Simson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jake Simson. Real-time updates on events, politics, business and more.
Septerna Raises $150M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Jake Simson Mirae Asset Financial Group South San Francisco Third Rock Ventures Samsara Biocapital Catalio Capital Management
Source: finsmes.com
Bicara Therapeutics Raises $108M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Cedilla Therapeutics raised $25M; Closes $82.6M Series B
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United Kingdom Alexandra Glucksmann Jake Simson Cedilla Therapeutics Janus Henderson Investors Woodline Partners
Source: finsmes.com
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway News provided by Share this article Share this article SAN MATEO, Calif., Dec. 16, 2020 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the closing of a $30 million Series C financing. The company anticipates advancing its clinical candidate into first-in-...
Source: prnewswire.com